Loading
Latest filing published 17 Aug 2026 for AN2 Therapeutics, Inc., €5.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 17 August 2026, Readnour Robin Shane disclosed a transaction of €5.2M in AN2 Therapeutics, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration